Holen Sie sich die Stockscreener-App
1.63
7.39%
-0.13
Vorhandelsmarkt:
1.62
-0.010
-0.61%
Hookipa Pharma Inc Aktie (HOOK) Neueste Nachrichten
Hookipa Pharma stock hits 52-week low at $1.56 amid downturn - Investing.com India
Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN
BRIEF—Proposed combination of Poolbeg with HOOKIPA called off - The Pharma Letter
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia
Poolbeg slumps as Hookipa merger is called off - pharmaphorum
Hookipa Pharma (NASDAQ:HOOK) Shares Down 4.8% – Time to Sell? - Defense World
Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA - Share Talk
Poolbeg merger off after HOOKIPA ends discussions - Proactive Investors USA
Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger - TradingView
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewswire
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma - Investing.com India
Failed Merger: Why HOOKIPA Pharma Walked Away from Poolbeg Deal - StockTitan
Hookipa Pharma stock hits 52-week low at $1.71 amid downturn - MSN
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial - Yahoo Finance
Hookipa Pharma Files Petition to Validate Stockholder Actions at Annual Meetings - Defense World
HOOKIPA completes enrollment for HIV vaccine trial By Investing.com - Investing.com Nigeria
HOOKIPA Pharma seeks court validation for stockholder actions By Investing.com - Investing.com Australia
HOOKIPA completes enrollment for HIV vaccine trial - Investing.com India
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b - GlobeNewswire
Game-Changing HIV Vaccine Trial Fully Enrolled: HOOKIPA's Path to Potential Cure - StockTitan
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment… - Informazione.it
Poolbeg Agrees to Bid Deadline Extension for Possible Hookipa Pharma Deal - MarketWatch
Poolbeg and HOOKIPA given more time to agree merger deal - Proactive Investors UK
Poolbeg Pharma PLC (AIM:POLB) Offer Update – Extension to PUSU Deadline - Share Talk
Poolbeg Pharma granted extension to PUSU Deadline - DirectorsTalk Interviews
Poolbeg Pharma and HOOKIPA Extend Merger Deadline Amid Positive Discussions - TipRanks
HOOKIPA Pharma seeks court validation for stockholder actions - MSN
Hookipa Pharma Seeks Validation for Stockholder Meetings - TipRanks
HOOK (HOOKIPA Pharma) Shares Outstanding (EOP) : 12.05 Mil (As of Sep. 2024) - GuruFocus.com
Hookipa Pharma stock hits 52-week low at $1.73 amid market challenges - Investing.com Nigeria
Geode Capital Management LLC Cuts Stake in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
HC Wainwright Reiterates Neutral Rating for Hookipa Pharma (NASDAQ:HOOK) - Defense World
HOOKIPA Pharma explores acquisition of Poolbeg Pharma By Investing.com - Investing.com South Africa
HOOKIPA Pharma explores acquisition of Poolbeg Pharma - Investing.com
Poolbeg Pharma notes Gilead interest in Hookipa fundraise -January 10, 2025 at 11:08 am EST - Marketscreener.com
Poolbeg Pharma PLC (AIM:POLB) Update Potential Combination of Poolbeg & HOOKIPA - Share Talk
Poolbeg Pharma update on potential combination with HOOKIPA - DirectorsTalk Interviews
Poolbeg Pharma plc ('Poolbeg”) and HOOKIPA Pharma Inc. ('HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - The Manila Times
Poolbeg Pharma and HOOKIPA Explore Potential Merger Amid Gilead’s Interest - TipRanks
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. - GlobeNewswire
Gilead Sciences Backs HOOKIPA-Poolbeg Merger Talks with $8.7M Funding Commitment - StockTitan
HOOKIPA Pharma discloses position in takeover code filing By Investing.com - Investing.com Nigeria
0.53%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):